Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Elemental Impurities (ICH Q3D) in Pharmaceutical Intermediates: A Buyer’s Guide
This guide explains the four element classes, the 30% control threshold that determines whether routine testing is required, the difference between ICP-MS and ICP-OES analytical ...
Read More →
Chiral Purity and Enantiomeric Excess (ee%) in Pharmaceutical Intermediates
This guide explains what ee% measures, why it differs from optical purity, how chiral HPLC validates stereochemical integrity, and which COA fields separate genuine process ...
Read More →
Empagliflozin Intermediate Sourcing: Buyers Guide
This buyer's guide maps the Boehringer Ingelheim synthesis route, identifies four commercially critical intermediates with CAS numbers, explains why six chiral centers create six separate ...
Read More →
Pharmaceutical Intermediate Storage Conditions: What Buyers Must Know
This guide explains three degradation pathways triggered by improper storage (hydrolysis, photodegradation, and thermal decomposition), decodes what "Store at CRT" actually means under USP ...
Read More →